Cargando…

High GCLC level in tumor tissues is associated with poor prognosis of hepatocellular carcinoma after curative resection

Glutamate-cysteine ligase catalytic subunit (GCLC) has been reported to overexpress in a variety types of cancer and be related with tumor progression and drug resistance. However, little has been known about GCLC's prognostic significance and biological roles in hepatocellular carcinoma (HCC)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Jialei, Zhou, Chenhao, Ma, Qianni, Chen, Wanyong, Atyah, Manar, Yin, Yirui, Fu, Peiyao, Liu, Shuang, Hu, Bo, Ren, Ning, Zhou, Haijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603424/ https://www.ncbi.nlm.nih.gov/pubmed/31293636 http://dx.doi.org/10.7150/jca.29769

Ejemplares similares

High RPS11 level in hepatocellular carcinoma associates with poor prognosis after curative resection
por: Zhou, Chenhao, et al.
Publicado: (2020)

Low expression of WW domain‐containing oxidoreductase associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
por: Zhou, Chenhao, et al.
Publicado: (2018)

Association of WWOX rs9926344 polymorphism with poor prognosis of hepatocellular carcinoma
por: Chen, Wanyong, et al.
Publicado: (2018)

Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma
por: Weng, Jialei, et al.
Publicado: (2021)

Development and validation of a nomogram combining hematological and imaging features for preoperative prediction of microvascular invasion in hepatocellular carcinoma patients
por: Zhou, Qiang, et al.
Publicado: (2021)

SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway
por: Zhou, Chenhao, et al.
Publicado: (2020)

Integrated Analysis of Copy Number Variations and Gene Expression Profiling in Hepatocellular carcinoma
por: Zhou, Chenhao, et al.
Publicado: (2017)

The association between KLF4 as a tumor suppressor and the prognosis of hepatocellular carcinoma after curative resection
por: Xue, Min, et al.
Publicado: (2020)

GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism()
por: Zhou, Qiang, et al.
Publicado: (2022)

The Age-Specific Features and Clinical Significance of NRF2 and MAPK10 Expression in HCC Patients
por: Atyah, Manar, et al.
Publicado: (2022)

A robust 6-mRNA signature for prognosis prediction of pancreatic ductal adenocarcinoma
por: Zhou, Chenhao, et al.
Publicado: (2019)

A Novel mRNA Signature Related to Immunity to Predict Survival and Immunotherapy Response in Hepatocellular Carcinoma
por: Zhou, Chenhao, et al.
Publicado: (2022)

A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma
por: Zhou, Chenhao, et al.
Publicado: (2019)

Overexpression of semaphorin 3A promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma after curative resection
por: Hu, Zhi-Qiang, et al.
Publicado: (2016)

Elevated Serum S100A9 Indicated Poor Prognosis in Hepatocellular Carcinoma after Curative Resection
por: Meng, Jun, et al.
Publicado: (2019)

Downregulation of LncRNA GCLC-1 Promotes Microcystin-LR-Induced Malignant Transformation of Human Liver Cells by Regulating GCLC Expression
por: Huang, Xinglei, et al.
Publicado: (2023)

Systemic Hepatic-Damage Index for Predicting the Prognosis of Hepatocellular Carcinoma after Curative Resection
por: Gao, Xing-hui, et al.
Publicado: (2017)

Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation
por: Sun, Jialei, et al.
Publicado: (2021)

Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection
por: Shen, Shun-Li, et al.
Publicado: (2014)

Integrated analysis of the impact of age on genetic and clinical aspects of hepatocellular carcinoma
por: Atyah, Manar, et al.
Publicado: (2018)

Downregulation of Epstein-Barr virus-induced gene 3 is associated with poor prognosis of hepatocellular carcinoma after curative resection
por: Song, Qingjie, et al.
Publicado: (2018)

Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection
por: Hu, Zhi-Qiang, et al.
Publicado: (2020)

Laparoscopic versus open left hemihepatectomy for hepatocellular carcinoma: a propensity score matching analysis
por: Yi, Yong, et al.
Publicado: (2020)

High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma
por: Liu, Wei-Ren, et al.
Publicado: (2014)

Apolipoprotein A1: a novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resection
por: Ma, Xiao-Lu, et al.
Publicado: (2016)

High S100A9(+) cell density predicts a poor prognosis in hepatocellular carcinoma patients after curative resection
por: Liao, Jing, et al.
Publicado: (2021)

Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection
por: Kuang, Xuejun, et al.
Publicado: (2018)

The various aspects of genetic and epigenetic toxicology: testing methods and clinical applications
por: Ren, Ning, et al.
Publicado: (2017)

ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection
por: Hwang, Hye Won, et al.
Publicado: (2015)

Nerve invasion as an independent predictor of poor prognosis in gastric cancer after curative resection
por: Li, Chunsheng, et al.
Publicado: (2022)

Combination of Intratumoral Invariant Natural Killer T Cells and Interferon-Gamma Is Associated with Prognosis of Hepatocellular Carcinoma after Curative Resection
por: Xiao, Yong-Sheng, et al.
Publicado: (2013)

Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection
por: Wang, Jia-Xing, et al.
Publicado: (2014)

High expression of Oct4 and Nanog predict poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection
por: Zhang, Mei-xia, et al.
Publicado: (2019)

TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection
por: Wang, Cheng-Hao, et al.
Publicado: (2015)

HBV is a risk factor for poor patient prognosis after curative resection of hepatocellular carcinoma: A retrospective case–control study
por: Li, Zhonghu, et al.
Publicado: (2016)

Decreased expression of LKB1 predicts poor prognosis in pancreatic neuroendocrine tumor patients undergoing curative resection
por: Li, Dezhi, et al.
Publicado: (2018)

Silencing GTSE-1 expression inhibits proliferation and invasion of hepatocellular carcinoma cells
por: Guo, Lei, et al.
Publicado: (2016)

Prognosis after intrahepatic recurrence in the patients who underwent curative resection for hepatocellular carcinoma
por: Lee, Juhyeon, et al.
Publicado: (2020)

Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma
por: Yan, Qing, et al.
Publicado: (2022)

Associations of GCLM, gclc and GSTP1 gene polymorphisms and antituberculosis drugs-induced hepatitis
por: Kim, Sang-Heon, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tc5coftfv43lc2k1es4ptg5jet